印度分子诊断控制市场，按产品（独立控制、仪器特定控制）、分析物类型（单一分析物控制、多分析物控制）、应用（传染病、肿瘤学、基因检测、其他）、最终用户（临床实验室、医院、IVD 制造商和合同研究组织、学术和研究机构、其他）、分销渠道（零售、直接招标）划分 - 行业趋势和预测到 2031 年。
印度分子诊断控制市场分析和规模
分子诊断对照对于实验室检测的质量保证至关重要。它们可作为具有已知特定核酸或其他分子靶标浓度的标准化样本。实验室使用这些对照来验证和监控其分子诊断检测的性能。分子诊断对照有助于评估检测结果的准确性和精确度。通过使用具有已知靶标生物分子浓度的对照，实验室可以验证其检测方法是否提供可靠且一致的结果。在诊断领域，遵守监管标准至关重要。监管机构通常要求进行分子诊断对照，以确保实验室符合质量和准确性标准。遵守法规有助于维护诊断检测的完整性。
Data Bridge Market Research 分析，印度分子诊断控制市场规模在 2023 年为 4614 万美元，到 2031 年可能达到 1.2887 亿美元，预计在预测期内复合年增长率为 13.7%。由于传染病的流行，“临床实验室”在分子诊断控制市场的最终用户部分占据主导地位。
除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察之外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
印度分子诊断控制市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（独立控制、仪器特定控制）、分析物类型（单一分析物控制、多分析物控制）、应用（传染病、肿瘤学、基因检测、其他）、最终用户（临床实验室、医院、IVD 制造商和合同研究组织、学术和研究机构、其他）、分销渠道（零售、直接招标） |
|
覆盖国家 |
印度 |
|
涵盖的市场参与者 |
Thermo Fisher Scientific Inc.（美国）、ASURAGEN, INC.（美国）、Merck KGaA（德国）、SERACARE LIFE SCIENCES（美国）、Bio-Rad Laboratories, Inc.（美国）、bioMérieux SA（法国）、Abbott（美国）、Microbiologics（美国） |
|
市场机会 |
|
市场定义
分子诊断对照是分子诊断测试中使用的特定材料，用于确保测试过程结果的准确性、可靠性和精确度。分子诊断涉及对遗传物质（例如 DNA 或 RNA）的分析，以检测和监测各种疾病，包括遗传疾病、传染病和某些类型的癌症。
印度分子诊断控制市场动态
驱动程序
- 疾病发病率上升
传染病、遗传性疾病和慢性病的发病率不断上升，推动了对准确可靠的诊断检测的需求。分子诊断控制在确保这些检测的精确性和可靠性方面发挥着至关重要的作用，有助于有效的疾病管理。
- 分子诊断的进展
分子诊断技术（包括聚合酶链式反应(PCR)、核酸测序和其他分子技术）的不断进步正在扩大诊断检测的能力。开发新的检测方法通常需要相应的分子诊断控制来进行验证和质量保证。
机会
- 即时诊断检测的快速增长
随着即时诊断检测（即在患者附近而非集中实验室进行诊断检测）的兴起，对可靠分子诊断控制的需求也随之增加。这些控制对于维持在传统实验室环境之外进行的检测的准确性至关重要。
克制/挑战
- 严格的监管审批流程
诊断控制的监管审批流程可能冗长而严格。遵守监管要求是进入市场的必要条件，但它可能带来时间和资源方面的挑战。审批延迟可能会减缓新分子诊断控制进入市场的速度。
近期发展
- 2021 年 6 月，Bio-Rad Laboratories, Inc. 宣布已与 Seegene, Inc. 建立合作伙伴关系，以开发和商业化传染病分子诊断产品。该公司的这种合作关系增加了其在市场上的需求和销量
印度分子诊断控制市场范围
分子诊断控制市场根据产品、分析物类型、应用、最终用户和分销渠道进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 独立控制
- 仪器特定控制
分析物类型
- 单一分析物对照
- 多分析物控制
应用
- 传染病
- 肿瘤学
- 基因检测
- 其他的
最终用户
- 临床实验室
- 医院
- IVD 制造商和合同研究组织
- 学术及研究机构
- 其他的
分销渠道
- 零售销售
- 直接招标
医疗保健基础设施增长安装基础和新技术渗透
分子诊断控制市场还为您提供了详细的市场分析，包括每个国家在资本设备医疗保健支出的增长情况、分子诊断控制市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管场景的变化及其对全球分子诊断控制市场的影响。
竞争格局和印度分子诊断控制市场份额分析
分子诊断控制市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对分子诊断控制市场的关注有关。
分子诊断控制市场的一些主要参与者包括：
- 赛默飞世尔科技公司（美国）
- ASURAGEN, INC.（美国）
- 默克集团（德国）
- SERACARE 生命科学（美国）
- Bio-Rad Laboratories, Inc.（美国）
- 生物梅里埃公司（法国）
- 雅培（美国）
- 微生物学（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of India molecular diagnostic controls market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- PRODUCT LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET application COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- REGULATIONS OF EUROPE, AFRICA, AND INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET
- market overview
- DRIVERS
- INCREASE IN PREVALENCE OF INFECTIOUS DISEASES AND CANCER
- GROWING ADOPTION OF THIRD-PARTY QUALITY CONTROLS
- RISE IN CLEARANCE FROM REGULATORY AGENCIES
- INCREASE IN NUMBER OF ACCREDITED CLINICAL LABORATORIES
- RESTRAINT
- HIGH COSTS ASSOCIATED WITH QUALITY CONTROL PROCESS
- OPPORTUNITIES
- COLLABORATIONS BETWEEN ACADEMIC INSTITUTIONS, HOSPITALS, AND COMPANIES
- INCREASE IN RESEARCH ON CANCER BIOMARKERS
- ADVANCED DIAGNOSIS INFRASTRUCTURE
- CHALLENGE
- UNFAVORABLE REIMBURSEMENT POLICIES FOR MOLECULAR TESTS
- IMPACT OF COVID-19 ON INDIA MOLECULAR DIAGNOSTICS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19
- CONCLUSION
- India molecular diagnostic controls MARKET, BY PRODUCT
- overview
- Independent Controls
- Instrument Specific Controls
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next Generation Sequencing
- In Situ Hybridization (ISH)
- DNA Microarray
- India molecular diagnostic controls MARKET, BY analyte TYPE
- overview
- Single Analyte Controls
- Multi Analyte Controls
- India molecular diagnostic controls MARKET, BY application
- overview
- Infectious Disease
- Hepatitis
- Human papillomavirus (HPV)
- HIV
- Health care-associated infections (HAIs)
- Influenza
- Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG)
- TB
- Others
- Oncology
- Genetic Testing
- Others
- India molecular diagnostic controls MARKET, BY end user
- overview
- Clinical Laboratories
- Hospitals
- IVD Manufacturers & Contract Research Organisations
- Academic & Research Institutes
- Others
- India molecular diagnostic controls MARKET, BY distribution channel
- overview
- Retail Sales
- Direct Tenders
- India Molecular Diagnostic Controls Market, By Region
- INDIA
- EUROPE MOLECULAR DIAGNOSTIC CONTROLS MARKET, COMPANY landscape
- company share analysis: India
- swot analysis
- Company profile
- Bio-Rad Laboratories, Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Randox Laboratories Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Technopath Clinical Diagnostics
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Thermo fisher Scientific Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ASURAGEN, INC.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BIOMÉRIEUX SA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- EKF Diagnostics Holdings plc
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ELITechGroup
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Helena Laboratories (UK) Limited trading
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Merck KGaA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- microbiologics
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Molbio Diagnostics Pvt. Ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- SERACARE LIFE SCIENCES
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- QNOSTICS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- QUIDEL CORPORATION
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
表格列表
TABLE 1 India molecular diagnostic controls Market, By product, 2019-2028 (USD MILLION)
TABLE 2 India Independent Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 3 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 4 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)
TABLE 5 India molecular diagnostic controls Market, By Analyte type, 2019-2028 (USD MILLION)
TABLE 6 India Single Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 7 India Multi Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 8 India molecular diagnostic controls Market, By application, 2019-2028 (USD MILLION)
TABLE 9 India Infectious Disease in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 10 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 11 India Oncology in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 12 India Genetic Testing in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 13 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 14 India molecular diagnostic controls Market, By end user, 2019-2028 (USD MILLION)
TABLE 15 India Clinical Laboratories in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 16 India Hospitals in Molecular Diagnostic Controls Market, By Region r, 2019-2028 (USD Million)
TABLE 17 India IVD Manufacturers & Contract Research Organisations in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 18 India Academic & Research Institutes in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 19 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 20 India molecular diagnostic controls Market, By distribution channel, 2019-2028 (USD MILLION)
TABLE 21 India Retail Sales in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 22 India Direct Tenders in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 23 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)
TABLE 24 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)
TABLE 25 India Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)
TABLE 26 India Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 27 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 28 India Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)
TABLE 29 India Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)
图片列表
FIGURE 1 India molecular diagnostic controls MARKET: SEGMENTATION
FIGURE 2 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DATA TRIANGULATION
FIGURE 3 India molecular diagnostic controls market: DROC ANALYSIS
FIGURE 4 India molecular diagnostic controls market: Global VS. REGIONAL MARKET ANALYSIS
FIGURE 5 India molecular diagnostic controls market: COMPANY RESEARCH ANALYSIS
FIGURE 6 India molecular diagnostic controls market: MULTIVARIATE MODELLING
FIGURE 7 India molecular diagnostic controls market: INTERVIEW DEMOGRAPHICS
FIGURE 8 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 India molecular diagnostic controls market: MARKET application COVERAGE GRID
FIGURE 11 India molecular diagnostic controls market: SEGMENTATION
FIGURE 12 Europe is expected to DOMINATE THE India molecular diagnostic controls market AND india IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 increasing prevalence of infectious diseases and cancer is expected to DRIVe THE India molecular diagnostic controls market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 product SEGMENT is expected to account for the largest share of the India molecular diagnostic controls MARKET in 2021 & 2028
FIGURE 15 InDIA is the fastest growing market FOR the India Molecular diagnostic controls MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF India molecular diagnostics controls Market
FIGURE 17 India molecular diagnostic controls MARKET: BY product, 2020
FIGURE 18 India molecular diagnostic controls MARKET: BY product, 2021-2028 (USD MILLION)
FIGURE 19 India molecular diagnostic controls MARKET: BY product, CAGR (2021-2028)
FIGURE 20 India molecular diagnostic controls MARKET: BY product, LIFELINE CURVE
FIGURE 21 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2020
FIGURE 22 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2021-2028 (USD MILLION)
FIGURE 23 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, CAGR (2021-2028)
FIGURE 24 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, LIFELINE CURVE
FIGURE 25 India molecular diagnostic controls MARKET: BY application, 2020
FIGURE 26 India molecular diagnostic controls MARKET: BY application, 2021-2028 (USD MILLION)
FIGURE 27 India molecular diagnostic controls MARKET: BY application, CAGR (2021-2028)
FIGURE 28 India molecular diagnostic controls MARKET: BY application, LIFELINE CURVE
FIGURE 29 India molecular diagnostic controls MARKET: BY end user, 2020
FIGURE 30 India molecular diagnostic controls MARKET: BY end user, 2021-2028 (USD MILLION)
FIGURE 31 India molecular diagnostic controls MARKET: BY end user, CAGR (2021-2028)
FIGURE 32 India molecular diagnostic controls MARKET: BY end user, LIFELINE CURVE
FIGURE 33 India molecular diagnostic controls MARKET: BY distribution channel, 2020
FIGURE 34 India molecular diagnostic controls MARKET: BY distribution channel, 2021-2028 (USD MILLION)
FIGURE 35 India molecular diagnostic controls MARKET: BY distribution channel, CAGR (2021-2028)
FIGURE 36 India molecular diagnostic controls MARKET: BY distribution channel, LIFELINE CURVE
FIGURE 37 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: company share 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
